Table of Contents 1 Market Overview 1.1 Peripheral Intervention Drug-Eluting Devices Introduction 1.2 Market Analysis by Type 1.2.1 Plain Old Balloon Angioplasty (POBA) 1.2.2 Percutaneous Transluminal Angioplasty (PTA) 1.3 Market Analysis by Applications 1.3.1 Drug-Eluting Balloons 1.3.2 Drug-Eluting Stents 1.4 Market Analysis by Regions 1.4.1 North America (United States, Canada and Mexico) 1.4.1.1 United States Market States and Outlook (2013-2023) 1.4.1.2 Canada Market States and Outlook (2013-2023) 1.4.1.3 Mexico Market States and Outlook (2013-2023) 1.4.2 Europe (Germany, France, UK, Russia and Italy) 1.4.2.1 Germany Market States and Outlook (2013-2023) 1.4.2.2 France Market States and Outlook (2013-2023) 1.4.2.3 UK Market States and Outlook (2013-2023) 1.4.2.4 Russia Market States and Outlook (2013-2023) 1.4.2.5 Italy Market States and Outlook (2013-2023) 1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) 1.4.3.1 China Market States and Outlook (2013-2023) 1.4.3.2 Japan Market States and Outlook (2013-2023) 1.4.3.3 Korea Market States and Outlook (2013-2023) 1.4.3.4 India Market States and Outlook (2013-2023) 1.4.3.5 Southeast Asia Market States and Outlook (2013-2023) 1.4.4 South America, Middle East and Africa 1.4.4.1 Brazil Market States and Outlook (2013-2023) 1.4.4.2 Egypt Market States and Outlook (2013-2023) 1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023) 1.4.4.4 South Africa Market States and Outlook (2013-2023) 1.4.4.5 Nigeria Market States and Outlook (2013-2023) 1.5 Market Dynamics 1.5.1 Market Opportunities 1.5.2 Market Risk 1.5.3 Market Driving Force 2 Manufacturers Profiles 2.1 Medtronic plc 2.1.1 Business Overview 2.1.2 Peripheral Intervention Drug-Eluting Devices Type and Applications 2.1.2.1 Product A 2.1.2.2 Product B 2.1.3 Medtronic plc Peripheral Intervention Drug-Eluting Devices Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.2 Boston Scientific Corporation 2.2.1 Business Overview 2.2.2 Peripheral Intervention Drug-Eluting Devices Type and Applications 2.2.2.1 Product A 2.2.2.2 Product B 2.2.3 Boston Scientific Corporation Peripheral Intervention Drug-Eluting Devices Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.3 Abbott Laboratories 2.3.1 Business Overview 2.3.2 Peripheral Intervention Drug-Eluting Devices Type and Applications 2.3.2.1 Product A 2.3.2.2 Product B 2.3.3 Abbott Laboratories Peripheral Intervention Drug-Eluting Devices Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.4 Cardinal Health 2.4.1 Business Overview 2.4.2 Peripheral Intervention Drug-Eluting Devices Type and Applications 2.4.2.1 Product A 2.4.2.2 Product B 2.4.3 Cardinal Health Peripheral Intervention Drug-Eluting Devices Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.5 B. Braun Melsungen AG 2.5.1 Business Overview 2.5.2 Peripheral Intervention Drug-Eluting Devices Type and Applications 2.5.2.1 Product A 2.5.2.2 Product B 2.5.3 B. Braun Melsungen AG Peripheral Intervention Drug-Eluting Devices Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.6 Biosensors International Group Ltd. 2.6.1 Business Overview 2.6.2 Peripheral Intervention Drug-Eluting Devices Type and Applications 2.6.2.1 Product A 2.6.2.2 Product B 2.6.3 Biosensors International Group Ltd. Peripheral Intervention Drug-Eluting Devices Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.7 C.R. Bard, Inc. 2.7.1 Business Overview 2.7.2 Peripheral Intervention Drug-Eluting Devices Type and Applications 2.7.2.1 Product A 2.7.2.2 Product B 2.7.3 C.R. Bard, Inc. Peripheral Intervention Drug-Eluting Devices Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.8 St. Jude Medical, Inc. 2.8.1 Business Overview 2.8.2 Peripheral Intervention Drug-Eluting Devices Type and Applications 2.8.2.1 Product A 2.8.2.2 Product B 2.8.3 St. Jude Medical, Inc. Peripheral Intervention Drug-Eluting Devices Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.9 The Lubrizol Corporation 2.9.1 Business Overview 2.9.2 Peripheral Intervention Drug-Eluting Devices Type and Applications 2.9.2.1 Product A 2.9.2.2 Product B 2.9.3 The Lubrizol Corporation Peripheral Intervention Drug-Eluting Devices Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.10 Terumo Corporation 2.10.1 Business Overview 2.10.2 Peripheral Intervention Drug-Eluting Devices Type and Applications 2.10.2.1 Product A 2.10.2.2 Product B 2.10.3 Terumo Corporation Peripheral Intervention Drug-Eluting Devices Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 3 Global Peripheral Intervention Drug-Eluting Devices Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017) 3.1 Global Peripheral Intervention Drug-Eluting Devices Sales and Market Share by Manufacturer (2016-2017) 3.2 Global Peripheral Intervention Drug-Eluting Devices Revenue and Market Share by Manufacturer (2016-2017) 3.3 Market Concentration Rate 3.3.1 Top 3 Peripheral Intervention Drug-Eluting Devices Manufacturer Market Share in 2017 3.3.2 Top 6 Peripheral Intervention Drug-Eluting Devices Manufacturer Market Share in 2017 3.4 Market Competition Trend 4 Global Peripheral Intervention Drug-Eluting Devices Market Analysis by Regions 4.1 Global Peripheral Intervention Drug-Eluting Devices Sales, Revenue and Market Share by Regions 4.1.1 Global Peripheral Intervention Drug-Eluting Devices Sales and Market Share by Regions (2013-2018) 4.1.2 Global Peripheral Intervention Drug-Eluting Devices Revenue and Market Share by Regions (2013-2018) 4.2 North America Peripheral Intervention Drug-Eluting Devices Sales and Growth Rate (2013-2018) 4.3 Europe Peripheral Intervention Drug-Eluting Devices Sales and Growth Rate (2013-2018) 4.4 Asia-Pacific Peripheral Intervention Drug-Eluting Devices Sales and Growth Rate (2013-2018) 4.5 South America Peripheral Intervention Drug-Eluting Devices Sales and Growth Rate (2013-2018) 4.6 Middle East and Africa Peripheral Intervention Drug-Eluting Devices Sales and Growth Rate (2013-2018) 5 North America Peripheral Intervention Drug-Eluting Devices by Countries 5.1 North America Peripheral Intervention Drug-Eluting Devices Sales, Revenue and Market Share by Countries 5.1.1 North America Peripheral Intervention Drug-Eluting Devices Sales and Market Share by Countries (2013-2018) 5.1.2 North America Peripheral Intervention Drug-Eluting Devices Revenue and Market Share by Countries (2013-2018) 5.2 United States Peripheral Intervention Drug-Eluting Devices Sales and Growth Rate (2013-2018) 5.3 Canada Peripheral Intervention Drug-Eluting Devices Sales and Growth Rate (2013-2018) 5.4 Mexico Peripheral Intervention Drug-Eluting Devices Sales and Growth Rate (2013-2018) 6 Europe Peripheral Intervention Drug-Eluting Devices by Countries 6.1 Europe Peripheral Intervention Drug-Eluting Devices Sales, Revenue and Market Share by Countries 6.1.1 Europe Peripheral Intervention Drug-Eluting Devices Sales and Market Share by Countries (2013-2018) 6.1.2 Europe Peripheral Intervention Drug-Eluting Devices Revenue and Market Share by Countries (2013-2018) 6.2 Germany Peripheral Intervention Drug-Eluting Devices Sales and Growth Rate (2013-2018) 6.3 UK Peripheral Intervention Drug-Eluting Devices Sales and Growth Rate (2013-2018) 6.4 France Peripheral Intervention Drug-Eluting Devices Sales and Growth Rate (2013-2018) 6.5 Russia Peripheral Intervention Drug-Eluting Devices Sales and Growth Rate (2013-2018) 6.6 Italy Peripheral Intervention Drug-Eluting Devices Sales and Growth Rate (2013-2018) 7 Asia-Pacific Peripheral Intervention Drug-Eluting Devices by Countries 7.1 Asia-Pacific Peripheral Intervention Drug-Eluting Devices Sales, Revenue and Market Share by Countries 7.1.1 Asia-Pacific Peripheral Intervention Drug-Eluting Devices Sales and Market Share by Countries (2013-2018) 7.1.2 Asia-Pacific Peripheral Intervention Drug-Eluting Devices Revenue and Market Share by Countries (2013-2018) 7.2 China Peripheral Intervention Drug-Eluting Devices Sales and Growth Rate (2013-2018) 7.3 Japan Peripheral Intervention Drug-Eluting Devices Sales and Growth Rate (2013-2018) 7.4 Korea Peripheral Intervention Drug-Eluting Devices Sales and Growth Rate (2013-2018) 7.5 India Peripheral Intervention Drug-Eluting Devices Sales and Growth Rate (2013-2018) 7.6 Southeast Asia Peripheral Intervention Drug-Eluting Devices Sales and Growth Rate (2013-2018) 8 South America Peripheral Intervention Drug-Eluting Devices by Countries 8.1 South America Peripheral Intervention Drug-Eluting Devices Sales, Revenue and Market Share by Countries 8.1.1 South America Peripheral Intervention Drug-Eluting Devices Sales and Market Share by Countries (2013-2018) 8.1.2 South America Peripheral Intervention Drug-Eluting Devices Revenue and Market Share by Countries (2013-2018) 8.2 Brazil Peripheral Intervention Drug-Eluting Devices Sales and Growth Rate (2013-2018) 8.3 Argentina Peripheral Intervention Drug-Eluting Devices Sales and Growth Rate (2013-2018) 8.4 Colombia Peripheral Intervention Drug-Eluting Devices Sales and Growth Rate (2013-2018) 9 Middle East and Africa Peripheral Intervention Drug-Eluting Devices by Countries 9.1 Middle East and Africa Peripheral Intervention Drug-Eluting Devices Sales, Revenue and Market Share by Countries 9.1.1 Middle East and Africa Peripheral Intervention Drug-Eluting Devices Sales and Market Share by Countries (2013-2018) 9.1.2 Middle East and Africa Peripheral Intervention Drug-Eluting Devices Revenue and Market Share by Countries (2013-2018) 9.2 Saudi Arabia Peripheral Intervention Drug-Eluting Devices Sales and Growth Rate (2013-2018) 9.3 UAE Peripheral Intervention Drug-Eluting Devices Sales and Growth Rate (2013-2018) 9.4 Egypt Peripheral Intervention Drug-Eluting Devices Sales and Growth Rate (2013-2018) 9.5 Nigeria Peripheral Intervention Drug-Eluting Devices Sales and Growth Rate (2013-2018) 9.6 South Africa Peripheral Intervention Drug-Eluting Devices Sales and Growth Rate (2013-2018) 10 Global Peripheral Intervention Drug-Eluting Devices Market Segment by Type 10.1 Global Peripheral Intervention Drug-Eluting Devices Sales, Revenue and Market Share by Type (2013-2018) 10.1.1 Global Peripheral Intervention Drug-Eluting Devices Sales and Market Share by Type (2013-2018) 10.1.2 Global Peripheral Intervention Drug-Eluting Devices Revenue and Market Share by Type (2013-2018) 10.2 Plain Old Balloon Angioplasty (POBA) Sales Growth and Price 10.2.1 Global Plain Old Balloon Angioplasty (POBA) Sales Growth (2013-2018) 10.2.2 Global Plain Old Balloon Angioplasty (POBA) Price (2013-2018) 10.3 Percutaneous Transluminal Angioplasty (PTA) Sales Growth and Price 10.3.1 Global Percutaneous Transluminal Angioplasty (PTA) Sales Growth (2013-2018) 10.3.2 Global Percutaneous Transluminal Angioplasty (PTA) Price (2013-2018) 11 Global Peripheral Intervention Drug-Eluting Devices Market Segment by Application 11.1 Global Peripheral Intervention Drug-Eluting Devices Sales Market Share by Application (2013-2018) 11.2 Drug-Eluting Balloons Sales Growth (2013-2018) 11.3 Drug-Eluting Stents Sales Growth (2013-2018) 12 Peripheral Intervention Drug-Eluting Devices Market Forecast (2018-2023) 12.1 Global Peripheral Intervention Drug-Eluting Devices Sales, Revenue and Growth Rate (2018-2023) 12.2 Peripheral Intervention Drug-Eluting Devices Market Forecast by Regions (2018-2023) 12.2.1 North America Peripheral Intervention Drug-Eluting Devices Market Forecast (2018-2023) 12.2.2 Europe Peripheral Intervention Drug-Eluting Devices Market Forecast (2018-2023) 12.2.3 Asia-Pacific Peripheral Intervention Drug-Eluting Devices Market Forecast (2018-2023) 12.2.4 South America Peripheral Intervention Drug-Eluting Devices Market Forecast (2018-2023) 12.2.5 Middle East and Africa Peripheral Intervention Drug-Eluting Devices Market Forecast (2018-2023) 12.3 Peripheral Intervention Drug-Eluting Devices Market Forecast by Type (2018-2023) 12.3.1 Global Peripheral Intervention Drug-Eluting Devices Sales Forecast by Type (2018-2023) 12.3.2 Global Peripheral Intervention Drug-Eluting Devices Market Share Forecast by Type (2018-2023) 12.4 Peripheral Intervention Drug-Eluting Devices Market Forecast by Application (2018-2023) 12.4.1 Global Peripheral Intervention Drug-Eluting Devices Sales Forecast by Application (2018-2023) 12.4.2 Global Peripheral Intervention Drug-Eluting Devices Market Share Forecast by Application (2018-2023) 13 Sales Channel, Distributors, Traders and Dealers 13.1 Sales Channel 13.1.1 Direct Marketing 13.1.2 Indirect Marketing 13.1.3 Marketing Channel Future Trend 13.2 Distributors, Traders and Dealers 14 Research Findings and Conclusion 15 Appendix 15.1 Methodology 15.2 Data Source

List of Tables and Figures Figure Peripheral Intervention Drug-Eluting Devices Picture Table Product Specifications of Peripheral Intervention Drug-Eluting Devices Figure Global Sales Market Share of Peripheral Intervention Drug-Eluting Devices by Types in 2017 Table Peripheral Intervention Drug-Eluting Devices Types for Major Manufacturers Figure Plain Old Balloon Angioplasty (POBA) Picture Figure Percutaneous Transluminal Angioplasty (PTA) Picture Figure Peripheral Intervention Drug-Eluting Devices Sales Market Share by Applications in 2017 Figure Drug-Eluting Balloons Picture Figure Drug-Eluting Stents Picture Figure United States Peripheral Intervention Drug-Eluting Devices Revenue (Value) and Growth Rate (2013-2023) Figure Canada Peripheral Intervention Drug-Eluting Devices Revenue (Value) and Growth Rate (2013-2023) Figure Mexico Peripheral Intervention Drug-Eluting Devices Revenue (Value) and Growth Rate (2013-2023) Figure Germany Peripheral Intervention Drug-Eluting Devices Revenue (Value) and Growth Rate (2013-2023) Figure France Peripheral Intervention Drug-Eluting Devices Revenue (Value) and Growth Rate (2013-2023) Figure UK Peripheral Intervention Drug-Eluting Devices Revenue (Value) and Growth Rate (2013-2023) Figure Russia Peripheral Intervention Drug-Eluting Devices Revenue (Value) and Growth Rate (2013-2023) Figure Italy Peripheral Intervention Drug-Eluting Devices Revenue (Value) and Growth Rate (2013-2023) Figure China Peripheral Intervention Drug-Eluting Devices Revenue (Value) and Growth Rate (2013-2023) Figure Japan Peripheral Intervention Drug-Eluting Devices Revenue (Value) and Growth Rate (2013-2023) Figure Korea Peripheral Intervention Drug-Eluting Devices Revenue (Value) and Growth Rate (2013-2023) Figure India Peripheral Intervention Drug-Eluting Devices Revenue (Value) and Growth Rate (2013-2023) Figure Southeast Asia Peripheral Intervention Drug-Eluting Devices Revenue (Value) and Growth Rate (2013-2023) Figure Brazil Peripheral Intervention Drug-Eluting Devices Revenue (Value) and Growth Rate (2013-2023) Figure Egypt Peripheral Intervention Drug-Eluting Devices Revenue (Value) and Growth Rate (2013-2023) Figure Saudi Arabia Peripheral Intervention Drug-Eluting Devices Revenue (Value) and Growth Rate (2013-2023) Figure South Africa Peripheral Intervention Drug-Eluting Devices Revenue (Value) and Growth Rate (2013-2023) Figure Nigeria Peripheral Intervention Drug-Eluting Devices Revenue (Value) and Growth Rate (2013-2023) Table Medtronic plc Basic Information, Manufacturing Base and Competitors Table Medtronic plc Peripheral Intervention Drug-Eluting Devices Type and Applications Table Medtronic plc Peripheral Intervention Drug-Eluting Devices Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table Boston Scientific Corporation Basic Information, Manufacturing Base and Competitors Table Boston Scientific Corporation Peripheral Intervention Drug-Eluting Devices Type and Applications Table Boston Scientific Corporation Peripheral Intervention Drug-Eluting Devices Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table Abbott Laboratories Basic Information, Manufacturing Base and Competitors Table Abbott Laboratories Peripheral Intervention Drug-Eluting Devices Type and Applications Table Abbott Laboratories Peripheral Intervention Drug-Eluting Devices Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table Cardinal Health Basic Information, Manufacturing Base and Competitors Table Cardinal Health Peripheral Intervention Drug-Eluting Devices Type and Applications Table Cardinal Health Peripheral Intervention Drug-Eluting Devices Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table B. Braun Melsungen AG Basic Information, Manufacturing Base and Competitors Table B. Braun Melsungen AG Peripheral Intervention Drug-Eluting Devices Type and Applications Table B. Braun Melsungen AG Peripheral Intervention Drug-Eluting Devices Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table Biosensors International Group Ltd. Basic Information, Manufacturing Base and Competitors Table Biosensors International Group Ltd. Peripheral Intervention Drug-Eluting Devices Type and Applications Table Biosensors International Group Ltd. Peripheral Intervention Drug-Eluting Devices Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table C.R. Bard, Inc. Basic Information, Manufacturing Base and Competitors Table C.R. Bard, Inc. Peripheral Intervention Drug-Eluting Devices Type and Applications Table C.R. Bard, Inc. Peripheral Intervention Drug-Eluting Devices Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table St. Jude Medical, Inc. Basic Information, Manufacturing Base and Competitors Table St. Jude Medical, Inc. Peripheral Intervention Drug-Eluting Devices Type and Applications Table St. Jude Medical, Inc. Peripheral Intervention Drug-Eluting Devices Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table The Lubrizol Corporation Basic Information, Manufacturing Base and Competitors Table The Lubrizol Corporation Peripheral Intervention Drug-Eluting Devices Type and Applications Table The Lubrizol Corporation Peripheral Intervention Drug-Eluting Devices Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table Terumo Corporation Basic Information, Manufacturing Base and Competitors Table Terumo Corporation Peripheral Intervention Drug-Eluting Devices Type and Applications Table Terumo Corporation Peripheral Intervention Drug-Eluting Devices Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table Global Peripheral Intervention Drug-Eluting Devices Sales by Manufacturer (2016-2017) Figure Global Peripheral Intervention Drug-Eluting Devices Sales Market Share by Manufacturer in 2016 Figure Global Peripheral Intervention Drug-Eluting Devices Sales Market Share by Manufacturer in 2017 Table Global Peripheral Intervention Drug-Eluting Devices Revenue by Manufacturer (2016-2017) Figure Global Peripheral Intervention Drug-Eluting Devices Revenue Market Share by Manufacturer in 2016 Figure Global Peripheral Intervention Drug-Eluting Devices Revenue Market Share by Manufacturer in 2017 Figure Top 3 Peripheral Intervention Drug-Eluting Devices Manufacturer (Revenue) Market Share in 2017 Figure Top 6 Peripheral Intervention Drug-Eluting Devices Manufacturer (Revenue) Market Share in 2017 Figure Global Peripheral Intervention Drug-Eluting Devices Sales and Growth Rate (2013-2018) Figure Global Peripheral Intervention Drug-Eluting Devices Revenue and Growth Rate (2013-2018) Table Global Peripheral Intervention Drug-Eluting Devices Sales by Regions (2013-2018) Table Global Peripheral Intervention Drug-Eluting Devices Sales Market Share by Regions (2013-2018) Table Global Peripheral Intervention Drug-Eluting Devices Revenue by Regions (2013-2018) Figure Global Peripheral Intervention Drug-Eluting Devices Revenue Market Share by Regions in 2013 Figure Global Peripheral Intervention Drug-Eluting Devices Revenue Market Share by Regions in 2017 Figure North America Peripheral Intervention Drug-Eluting Devices Sales and Growth Rate (2013-2018) Figure Europe Peripheral Intervention Drug-Eluting Devices Sales and Growth Rate (2013-2018) Figure Asia-Pacific Peripheral Intervention Drug-Eluting Devices Sales and Growth Rate (2013-2018) Figure South America Peripheral Intervention Drug-Eluting Devices Sales and Growth Rate (2013-2018) Figure Middle East and Africa Peripheral Intervention Drug-Eluting Devices Sales and Growth Rate (2013-2018) Figure North America Peripheral Intervention Drug-Eluting Devices Revenue and Growth Rate (2013-2018) Table North America Peripheral Intervention Drug-Eluting Devices Sales by Countries (2013-2018) Table North America Peripheral Intervention Drug-Eluting Devices Sales Market Share by Countries (2013-2018) Figure North America Peripheral Intervention Drug-Eluting Devices Sales Market Share by Countries in 2013 Figure North America Peripheral Intervention Drug-Eluting Devices Sales Market Share by Countries in 2017 Table North America Peripheral Intervention Drug-Eluting Devices Revenue by Countries (2013-2018) Table North America Peripheral Intervention Drug-Eluting Devices Revenue Market Share by Countries (2013-2018) Figure North America Peripheral Intervention Drug-Eluting Devices Revenue Market Share by Countries in 2013 Figure North America Peripheral Intervention Drug-Eluting Devices Revenue Market Share by Countries in 2017 Figure United States Peripheral Intervention Drug-Eluting Devices Sales and Growth Rate (2013-2018) Figure Canada Peripheral Intervention Drug-Eluting Devices Sales and Growth Rate (2013-2018) Figure Mexico Peripheral Intervention Drug-Eluting Devices Sales and Growth Rate (2013-2018) Figure Europe Peripheral Intervention Drug-Eluting Devices Revenue and Growth Rate (2013-2018) Table Europe Peripheral Intervention Drug-Eluting Devices Sales by Countries (2013-2018) Table Europe Peripheral Intervention Drug-Eluting Devices Sales Market Share by Countries (2013-2018) Table Europe Peripheral Intervention Drug-Eluting Devices Revenue by Countries (2013-2018) Figure Europe Peripheral Intervention Drug-Eluting Devices Revenue Market Share by Countries in 2016 Figure Europe Peripheral Intervention Drug-Eluting Devices Revenue Market Share by Countries in 2017 Figure Germany Peripheral Intervention Drug-Eluting Devices Sales and Growth Rate (2013-2018) Figure UK Peripheral Intervention Drug-Eluting Devices Sales and Growth Rate (2013-2018) Figure France Peripheral Intervention Drug-Eluting Devices Sales and Growth Rate (2013-2018) Figure Russia Peripheral Intervention Drug-Eluting Devices Sales and Growth Rate (2013-2018) Figure Italy Peripheral Intervention Drug-Eluting Devices Sales and Growth Rate (2013-2018) Figure Asia-Pacific Peripheral Intervention Drug-Eluting Devices Revenue and Growth Rate (2013-2018) Table Asia-Pacific Peripheral Intervention Drug-Eluting Devices Sales by Countries (2013-2018) Table Asia-Pacific Peripheral Intervention Drug-Eluting Devices Sales Market Share by Countries (2013-2018) Figure Asia-Pacific Peripheral Intervention Drug-Eluting Devices Sales Market Share by Countries 2017 Table Asia-Pacific Peripheral Intervention Drug-Eluting Devices Revenue by Countries (2013-2018) Figure Asia-Pacific Peripheral Intervention Drug-Eluting Devices Revenue Market Share by Countries 2017 Figure China Peripheral Intervention Drug-Eluting Devices Sales and Growth Rate (2013-2018) Figure Japan Peripheral Intervention Drug-Eluting Devices Sales and Growth Rate (2013-2018) Figure Korea Peripheral Intervention Drug-Eluting Devices Sales and Growth Rate (2013-2018) Figure India Peripheral Intervention Drug-Eluting Devices Sales and Growth Rate (2013-2018) Figure Southeast Asia Peripheral Intervention Drug-Eluting Devices Sales and Growth Rate (2013-2018) Figure South America Peripheral Intervention Drug-Eluting Devices Revenue and Growth Rate (2013-2018) Table South America Peripheral Intervention Drug-Eluting Devices Sales by Countries (2013-2018) Table South America Peripheral Intervention Drug-Eluting Devices Sales Market Share by Countries (2013-2018) Figure South America Peripheral Intervention Drug-Eluting Devices Sales Market Share by Countries in 2017 Table South America Peripheral Intervention Drug-Eluting Devices Revenue by Countries (2013-2018) Table South America Peripheral Intervention Drug-Eluting Devices Revenue Market Share by Countries (2013-2018) Figure South America Peripheral Intervention Drug-Eluting Devices Revenue Market Share by Countries in 2017 Figure Brazil Peripheral Intervention Drug-Eluting Devices Sales and Growth Rate (2013-2018) Figure Argentina Peripheral Intervention Drug-Eluting Devices Sales and Growth Rate (2013-2018) Figure Colombia Peripheral Intervention Drug-Eluting Devices Sales and Growth Rate (2013-2018) Figure Middle East and Africa Peripheral Intervention Drug-Eluting Devices Revenue and Growth Rate (2013-2018) Table Middle East and Africa Peripheral Intervention Drug-Eluting Devices Sales by Countries (2013-2018) Table Middle East and Africa Peripheral Intervention Drug-Eluting Devices Sales Market Share by Countries (2013-2018) Figure Middle East and Africa Peripheral Intervention Drug-Eluting Devices Sales Market Share by Countries in 2017 Table Middle East and Africa Peripheral Intervention Drug-Eluting Devices Revenue by Countries (2013-2018) Table Middle East and Africa Peripheral Intervention Drug-Eluting Devices Revenue Market Share by Countries (2013-2018) Figure Middle East and Africa Peripheral Intervention Drug-Eluting Devices Revenue Market Share by Countries in 2013 Figure Middle East and Africa Peripheral Intervention Drug-Eluting Devices Revenue Market Share by Countries in 2017 Figure Saudi Arabia Peripheral Intervention Drug-Eluting Devices Sales and Growth Rate (2013-2018) Figure UAE Peripheral Intervention Drug-Eluting Devices Sales and Growth Rate (2013-2018) Figure Egypt Peripheral Intervention Drug-Eluting Devices Sales and Growth Rate (2013-2018) Figure Nigeria Peripheral Intervention Drug-Eluting Devices Sales and Growth Rate (2013-2018) Figure South Africa Peripheral Intervention Drug-Eluting Devices Sales and Growth Rate (2013-2018) Table Global Peripheral Intervention Drug-Eluting Devices Sales by Type (2013-2018) Table Global Peripheral Intervention Drug-Eluting Devices Sales Share by Type (2013-2018) Table Global Peripheral Intervention Drug-Eluting Devices Revenue by Type (2013-2018) Table Global Peripheral Intervention Drug-Eluting Devices Revenue Share by Type (2013-2018) Figure Global Plain Old Balloon Angioplasty (POBA) Sales Growth (2013-2018) Figure Global Plain Old Balloon Angioplasty (POBA) Price (2013-2018) Figure Global Percutaneous Transluminal Angioplasty (PTA) Sales Growth (2013-2018) Figure Global Percutaneous Transluminal Angioplasty (PTA) Price (2013-2018) Table Global Peripheral Intervention Drug-Eluting Devices Sales by Application (2013-2018) Table Global Peripheral Intervention Drug-Eluting Devices Sales Share by Application (2013-2018) Figure Global Drug-Eluting Stents Sales Growth (2013-2018) Figure Global Peripheral Intervention Drug-Eluting Devices Sales, Revenue and Growth Rate (2018-2023) Table Global Peripheral Intervention Drug-Eluting Devices Sales Forecast by Regions (2018-2023) Table Global Peripheral Intervention Drug-Eluting Devices Market Share Forecast by Regions (2018-2023) Figure North America Sales Peripheral Intervention Drug-Eluting Devices Market Forecast (2018-2023) Figure Europe Sales Peripheral Intervention Drug-Eluting Devices Market Forecast (2018-2023) Figure Asia-Pacific Sales Peripheral Intervention Drug-Eluting Devices Market Forecast (2018-2023) Figure South America Sales Peripheral Intervention Drug-Eluting Devices Market Forecast (2018-2023) Figure Middle East and Africa Sales Peripheral Intervention Drug-Eluting Devices Market Forecast (2018-2023) Table Global Peripheral Intervention Drug-Eluting Devices Sales Forecast by Type (2018-2023) Table Global Peripheral Intervention Drug-Eluting Devices Market Share Forecast by Type (2018-2023) Table Global Peripheral Intervention Drug-Eluting Devices Sales Forecast by Application (2018-2023) Table Global Peripheral Intervention Drug-Eluting Devices Market Share Forecast by Application (2018-2023) Table Distributors/Traders/ Dealers List

Medtronic plc Boston Scientific Corporation Abbott Laboratories Cardinal Health B. Braun Melsungen AG Biosensors International Group Ltd. C.R. Bard, Inc. St. Jude Medical, Inc. The Lubrizol Corporation Terumo Corporation